Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.54 |
| ▸ | KIF11 | P52732 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24416458 | 0.85 | ALDH1A1 (0.68) | HTTSMN1; SMN2LMNAALDH1A1HPGD | |
| SCHEMBL9453957 | 0.83 | CDK1 (0.68) | CDK1HTTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL1754979 | 0.83 | MAPT (0.61) | HTTMEN1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL25507774 | 0.81 | ALDH1A1 (0.53) | HTTSMN1; SMN2LMNAALDH1A1HPGD | |
| SCHEMBL5458066 | 0.81 | ALDH1A1 (0.77) | HTTMEN1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL12412636 | 0.80 | L3MBTL1 (0.62) | CDK1HTTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL13754522 | 0.80 | ALDH1A1 (0.58) | HTTMEN1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL12377252 | 0.79 | EPHX2 (0.70) | HTTMEN1KMT2AKIF11MAPT | |
| SCHEMBL19035689 | 0.79 | KIF11 (0.54) | CDK1HTTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL26156209 | 0.79 | GAA (0.63) | CDK1HTTMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7989422-B2 | Antibacterial agents | ALCHEMIA LIMITED (AU) | 2011-08-02 | — | — | US | disclosed |
| US-20090023669-A1 | Antibacterial Agents | ALCHEMIA LIMITED (AU) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023669-A1 | Antibacterial Agents | MRPL21, FUT6, FUT5 | CDK1 1536/4885HTT 4858/4885MEN1 2906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.